13F filer · CIK 1846237 ↗
Valor Management LLC
You are looking at Q1 2026. See the latest, Q2 2026 →
Reported value
$180.9M
+228% on the quarter before
Positions
5
2 new · 0 sold out
Top 10
100.0%
of the value
Est. gain
−$16.3M
on stocks held all quarter
Est. return
−29.5%
on those stocks since Q4 2025
Positions as of Mar 31, 2026, from Valor Management LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2025. Striped tiles are options.
Largest buys
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- BitGo~$103.2MNew · 0.0% → 57.0%+12,538,608 shares
- Brainsway Ltd~$35.3MAdded · 91.7% → 39.1%+2,657,475 shares
- Canton Strategic Holdings In~$3.5MNew · 0.0% → 2.0%+1,084,011 shares
Largest sells
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
No sales this quarter.
Holdings
As of Mar 31, 2026. Changes are in shares against Dec 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BitGoCOM SHS CL A · shares New | 57.0% | $103.2M | — | ||||||||
| Brainsway LtdSPONSORED ADS · shares +100% · price −30.1% | 39.1% | $70.6M | −$15.2M | ||||||||
| Canton Strategic Holdings InCOM · shares New | 2.0% | $3.5M | — | ||||||||
| Harmony Biosciences Hldgs InCOM · shares 0% · price −25.1% | 1.8% | $3.3M | −$1.1M | ||||||||
| Bioage Labs IncCOM · shares 0% · price +32.2% | 0.13% | $229,206 | +$55,827 | ||||||||
| Total · 5 positions | 100% | $180.9M | −$16.3M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2025 to Q1 2026: 3 stocks held throughout, down $16.3M (−29.5%).
- Bioage Labs Inc+$55,827+32%
- Harmony Biosciences Hldgs In−$1.1M−25%
- Brainsway Ltd−$15.2M−30%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $86.19B+47,550% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $180.9M+228% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $55.1M−18% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $67.3M−72% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $238.1M−1% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $240.6M−3% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $249.2M−48% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $474.6M+4% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $454.7M−5% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $479.6M+32% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $364.0M−2% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $371.5M−7% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $401.6M+6% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $379.7M−40% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $634.0M+22% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $520.5M−8% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $566.7M−14% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $655.5M+4% | SEC ↗ |
| Q4 2021 | Feb 9, 2022 | $627.7M | SEC ↗ |